Newcastle Disease: A Review

Document Type : Reviews articles

Abstract

Virulent strains of Newcastle disease virus (NDV) can cause severe damage to tissues in the gastrointestinal tract, respiratory and reproductive organs, in addition to neurological disorders and high mortality in poultry. Many countries adapt regular vaccine application for disease control. Nevertheless, virulent NDV is still endemic, impacting the poultry industry. Accordingly, continuous virus detection and identification are required to determine the epidemiological situation of the disease and to identify the widely distributed viral strains. Additionally, genotyping of the circulating strains along with vaccination with the genotype-matched ND vaccines are crucial for disease control. Both fusion (F) and haemagglutinin– neuraminidase (HN) proteins are surface proteins that can play major roles in infection and antigenicity of NDV. The site of cleavage of fusion protein that found at positions 112 to 117 of the precursor protein, can determine viral pathogenicity. haemagglutinin– neuraminidase is a multifunctional protein that is involved in interaction with F protein to promote fusion, receptor recognition and removal, and preventing viral self-aggregation.
 

Keywords

Main Subjects


Newcastle disease: a review

Hamdi M. Sallam

 

Reference Laboratory for Veterinary Quality Control on Poultry Production, Damanhour Branch, Animal Health Research Institute, Agricultural Research Center, Egypt.

Key words: Newcastle disease virus, Avulavirus, fusion protein, haemagglutinin–

neuraminidase.

Abstract

Virulent strains of Newcastle disease virus (NDV) can cause severe damage to tissues in the gastrointestinal tract, respiratory and reproductive organs, in addition to neurological disorders and high mortality in poultry. Many countries adapt regular vaccine application for disease control. Nevertheless, virulent NDV is still endemic, impacting the poultry industry. Accordingly, continuous virus detection and identification are required to determine the epidemiological situation of the disease and to identify the widely distributed viral strains. Additionally, genotyping of the circulating strains along with vaccination with the genotype-matched ND vaccines are crucial for disease control. Both fusion (F) and haemagglutinin– neuraminidase (HN) proteins are surface proteins that can play major roles in infection and antigenicity of NDV. The site of cleavage of fusion protein that found at positions 112 to 117 of the precursor protein, can determine viral pathogenicity. haemagglutinin– neuraminidase is a multifunctional protein that is involved in interaction with F protein to promote fusion, receptor recognition and removal, and preventing viral self-aggregation.

  1. Introduction:

Newcastle disease (ND) is seen as one of the economically important and highly contagious diseases affecting wide range of avian species (Rauw et al., 2009; da Silva et al., 2020; AbdElfatah et al., 2021). Newcastle disease virus (NDV) is the cause of the disease and is also known as avian orthoavulavirus 1 or avian paramyxovirus 1 (APMV-1) that has multiple basic amino acids at the C-terminus of F2 protein with phenylalanine residue at position 117 corresponding to the N-terminus of the F1 protein and that can induce 0.7 or greater intracerebral pathogenicity index (ICPI) in day old chicks (Swayne and King, 2003 and OIE 2018). This virus can lead to a severe, highly transmissible respiratory infection in poultry causing harm to the central nervous system and gastrointestinal tract (Mao et al., 2022). The ND disease is one of the diseases that require notification to the World Organization for Animal Health (OIE) and has been recognized as a significant limitation to the growth of the poultry sector.  Its effect is more catastrophic in underdeveloped nations where the traditional poultry sector is prevalent (Brown and Bevins 2017 and Dzogbema et al., 2021). This virus is widespread in numerous regions globally and has been reported to cause widespread outbreaks in domestic poultry on six of the seven continents and capable of causing 100% mortality in unprotected bands (Brown and Bevins 2017 and Dzogbema et al., 2021).

NDV has the ability to cause infections in no fewer than 241 bird species, which make up 27 out of the 50 Aves orders. psittacine birds, Cormorants, and pigeons are commonly infected with NDV and can transmit the highly pathogenic virus to domestic poultry.

Low virulence (lentogenic) strains of the virus can also be found commonly in poultry and wild birds, such as waterfowl (Ravishankar et al., 2022). NDV has been present in Egypt since 1948, and the country remains endemic to this day. (Ali et al., 2022). NDV genotype VII became the dominant genotype in Egypt since 2012 (Amer et al., 2019). Despite employing vaccination and other control measures to curtail this disease, it is still frequently reported. This study was done to present the available information about ND with especial focus on NDV structure.

 

  1. Virus classification and structure:

2.1. Virus classification:

Newcastle disease virus, the enveloped virus, belongs to genus Avulavirus within family Paramyxoviridae. It has negative sense non-segmented single-stranded genome (Lamb and Parks, 2007; Dimitrov et al., 2019; Dzogbema et al., 2021). The viral genome is made up from six genes in the sequence of 3'-NP-P-M-F-HN-L-5'.

 

Every gene is bordered by leader and trailer sequences and contains regulatory signals that control replication and transcription (Naz et al., 2022). Six structural polypeptides are encoded from these genes; nucleoprotein (NP), phosphoprotein (P), matrix protein (M), fusion protein (F), Haemagglutinin– neuraminidase (HN), and the large (L) RNA-dependent RNA polymerase (Chambers et al., 1986; Czeglédi et al., 2006, Lamb and Parks, 2007 and Naz et al., 2022). Based on the analysis of complete genome sequences of NDV, three varying genome sizes were identified (15,198; 15,192 and 15,186 nucleotides) upon which NDV strains were divided into two different classes (class I and class II) (Czeglédi et al., 2006). The class I NDV group consists of single genotype and contains non-virulent strains and subdivided into 3 sub-genotypes, meanwhile class II NDV is divided into 21 genotypes (I–XXI) that subdivided into several sub-genotypes. Genotypes I, II, III, and IV of class II NDV are ancient, meanwhile genotypes V, VI, and VII are recent strains and associated with majorly involved worldwide outbreaks (Aldous et al., 2004). Genotype VII is subdivided into 3 subgenotypes; VII.1.1 (formerly comprising sub-genotypes VIIb, VIId, VIIe, VIIj and VIIl), sub-genotype VII.1.2 (formerly known as sub-genotype VIIf) and sub-genotype VII.2 (formerly includes subgenotypes VIIa, VIIh, VIIi and VIIk) (Dimitrov et al., 2019 and Naz et al., 2022). Sub-genotype VII.1.1 is prevalent at commercial chicken flocks and wild birds in Egypt (Nagy et al., 2020, AbdElfatah et al., 2021) (figure, 1).

 

 

Figure 1. Representing some Egyptian NDV strains in relation to different subgenotypes of genotype VII that is prevalent in Egypt. The tree was constructed using MEGA11 software (Tamura et al. 2021).

 

2.2. Nucleoprotein (N protein):

Nucleoprotein (N) is made up of 489 amino acids with 53 kDa molecular weight. It is the protein that is found in the highest quantity and serves to shield the viral genetic material from the nuclease enzymes found in the host cells. This protein coats both full-length genomic (negative sense) and antigenomic (positive sense) RNAs to protect them from cellular nucleases (Kho et al., 2003 and Dortmans et al., 2010). By electron microscopy, it appears to hold a herringbone like structure. Along with the genomic RNA, N protein forms the helical nucleocapsid core structure of the virus and in association with the P, L proteins and genomic RNA forms the ribonucleoprotein complex (RNP) (the template for RNA synthesis). The interaction between N protein and viral RNA occurs via its amino-terminus (Errington and Emmerson, 1997). The interaction between the N-RNA template and the L protein is mediated by a tetramer of phosphoprotein, leading to prevention of random encapsidation of non-viral RNA. Moreover, the shift from transcription to replication is regulated via the complex formed between the P protein and the unassembled N protein. This interaction is mediated by both amino- and carboxy-terminals of the P protein. Different functions of the P–N complex are carried out during virus replication by different domains of the P proteins. Additionally, the carboxy-terminal residue (247–291) of P protein participates in P–N and P–P interaction (Jahanshiri et al., 2005).

2.3. Phosphoprotein (P protein):

P protein is encoded from three different mRNAs that are transcribed from P gene. This protein acts as the cofactor of the polymerase and two nonstructural W and V proteins. The protein is composed of 395 amino acids and its molecular weight is 42 kDa (Yusoff and Tan 2001). This protein is phosphorylated at specific threonine and serine residues and helps in stabilizing the L protein in the P–L complex that functions as viral RNA-dependent RNA polymerase. This complex carries out genomic replication (Dortmans et al., 2010). Moreover, P protein has been observed to have a role in the virulence of NDV depending on the cell type and viral strain (Dortmans et al., 2010).

2.4. The large polymerase protein (L protein):

L protein, the largest protein encoded from the NDV genome, is comprised of 2204 amino acids and has a weight of 250 kDa (Lamb and Parks, 2007). It serves as viral replicase and transcriptase during the infectious cycle via synthesize of viral mRNA and assisting in genomic RNA replication (Naz et al., 2022). During viral replication cycle, it is the last gene to be transcribed. Additionally, the L protein is also responsible for methylation, 5’ capping, and poly A polymerase activity on the newly synthetized mRNA (Dortmans et al., 2010; Lamb and Parks, 2007). The active viral polymerase is formed by the L and P protein together. The helical nucleoprotein complex that acts as a template is identified by the L-P complex to create a functional viral polymerase complex, as it was mentioned previously. The transcription activity and polymerase activity of domain III are carried out by six highly conserved amino acid residues QGDNQ (Lamb and Parks, 2007). Reports indicate that the L protein plays a role in the virulence of NDV by potentially enhancing viral RNA synthesis, thus influencing the virus's virulence. (Rout and Samal, 2008).

2.5. Matrix protein (M protein):

M protein is about 40 kDa by weight and is present right under the envelope and keeps the shape of the virus aids in the packaging and release of newly formed viruses. This protein is a fundamental protein containing various conserved hydrophobic regions and consists of 346 amino acids (Bellini and al., 1986). It interacts with both cytoplasmic domains of the F and HN glycoproteins and the nucleocapsid. Moreover, it plays a role in ribonucleoprotein condensation, particularly in the viral assembly and budding phases. Besides, The M protein inhibits the expression of host cell genes and blocks the export of messenger RNA (Kopecky and Lyles, 2003 and Dzogbema et al., 2021). During viral assembly, the association between N and M proteins is facilitated by the net positive charge of M protein. The M protein is present between nucleocapsid and lipid membrane and has hydrophobic nature with no membrane spanning peptides (Ganar et al., 2004).

The high conservation of the M protein among paramyxoviruses is indicated by the small number of non-synonymous base substitutions observed after mutations in the population. Depending on these findings, different NDV strains from different geographical locations can be classified (Seal et al., 2000). Additionally, virus budding is facilitated by interaction between M protein with the host cell plasma membrane. The M protein possesses its own nuclear localization sequences, so it can carry out nuclear localization without needing assistance from other NDV proteins. It has been observed that the M protein plays a crucial role in viral assembly, as shown by temperature sensitive mutants that do not produce enough M at sub-optimal temperatures (Peeples and Bratt, 1984).

 

2.6. Fusion protein (F protein):

Both fusion (F) and haemagglutinin– neuraminidase (HN) proteins are surface proteins and can play major roles in infection and antigenicity of NDV (de Leeuw, 2005 and Kim et al., 2011). The fusion between viral envelope and cell membrane is done with fusion protein (F) that is activated by the attachment of the HN protein to cellular receptors at viral penetration to the target cell (Smith et al., 2009).

After activation, the F protein aids in merging neighboring cells while cells undergo a change into syncytium-forming cells (Hernandez et al., 1996; Seth et al., 2007 and Yamakawa et al., 2007). The fusion protein consists of 553 amino acids and has a weight of 55 kDa (Chambers et al., 1986 and Seal et al., 2005). This protein is synthesized and glycosylated in the endoplasmic reticulum as an inactive precursor (F0) (Yusoff and Tan, 2001) and cleaved by host cell proteases into C-terminal F1 (55 kDa) and N terminal F2 (12.5 kDa) subunits that linked by a disulfide (-S-S-) bridge (Nagai et al., 1989 and Bossart et al., 2009). The cleavage site is situated at positions 112 and 117 within the fusion protein precursor (Bossart et al., 2013). Viral fusion with the host cell membrane is initiated by a fusion peptide (FP) which is formed by a sequence  of hydrophobic amino acids that is located at the N terminus of the F1 (Samal et al., 2012 and Selim et al., 2018). Mesogenic and velogenic strains contain  a cleavage site that is formed by at least 3 basic amino acids {lysine (K) and arginine (R)} and phenylalanine (F) that located at position 117 (Peeters et al., 1999; Römer-Oberdörfer et al., 2003 and de Leeuw et al., 2005). This site is cleaved by furin-like enzymes (intracellular proteases), resulting in forming F1 subunit that is suggested to contribute to neurological effects (Nagai et al., 1976 and Toyoda et al., 1987 and Kattenbelt et al., 2006). Whereas, monobasic or dibasic amino acid residues that are located at the cleavage site of the F protein of low virulent NDV render this protein insensitive to the intracellular proteases. In contrast, it depends (to get cleaved) on extracellular proteases (trypsin-like enzymes) located in the respiratory and digestive mucosa, allowing its tropism limited to these tissues (Tashiro et al., 1992 and Ganar et al., 2014). So, virulent strains are more invasive and cause systemic disease (Dzogbema et al., 2021). Virulence of NDV is decreased by substitution of the neutral amino acid glutamine at position 114 with a basic or acidic amino acid residue, suggesting the importance of the presence of a neutral along with basic amino acids at the cleavage site in proper binding of furin protease (Nagai et al., 1976 and Samal et al., 2011).

2.7. Hemagglutinin-Neuramidase (HN protein):

Hemagglutinin-Neuramidase (HN) is a type II transmembrane glycoprotein with a molecular weight of 74 kDa containing uncleaved signal sequence near its amino terminal that is fixed in the virus envelope (Sergel et al., 1993 and Bossart et al., 2009). This protein is abundant and present within the virus infected cells as a homotetramer with disulfide linked dimers. Its ectodomain consists of a long stalk supporting a terminal globular head (Ganar et al. 2014). HN is a multifunctional protein involved in prevention of viral self-aggregation, receptor recognition and removal, and interaction with F protein to promote fusion (Connaris et al., 2002; Connolly et al., 2009 and Ganar et al., 2014). Among the 14 cysteine residues present in the HN protein of NDV, 12 residues are conserved and form intramolecular disulfide linkages. Covalent linkage between HN proteins and subsequent structural integrity is occurred via the cysteine residue at position 123 (McGinnes and Morrison, 1994; Sheehan and Iorio, 1992). The interaction between HN and M proteins occurs via 26 conserved amino acids which are present at the cytoplasmic tail of HN protein. Mutation at any amino acid other than the first two amino acids can affect the viability of HN protein. The viral tropism is determined by HN protein, although that enterotropism does not seem to be affected by the size of HN protein (Zhao et al., 2013). Presence of different positions of stop codon resulted in the presence of different length of the HN protein in nature. The velogenic strains contain the shortest HN (571 amino acids), while the longest (616 amino acids) is present in lentogenic strains (Gorman et al., 1988). Both receptor recognition and neuraminidase properties of HN lie in the globular head and are highly conserved. Sialic acid-binding site that is oriented toward the target host membrane presents on the top of the globular head of HN (Iorio and Mahon, 2008). Additionally, antibody binding site presents also on the globular head (Mao et al., 2022). The stalk domain of HN is suggested to mediate the interaction of HN with the homologous F protein (Hu et al., 1992; Deng et al., 1995 and Melanson and Iorio, 2004). A stretch of conserved amino acids (residue 74 to 110) involving the heptad repeats (HR) 1 and 2 is considered to mediate this interaction. In addition, fusion is impaired after substitutions in the intervening sequences between HR1 and HR2 (Melanson and Iorio, 2004; Mirza and Iorio, 2013). HN heptad repeats was suggested to interact with HR1 and HR2 of F protein resulting in keeping them apart in order to provide conformational changes in the two proteins and disruption of HN–F interaction and thus release of fusion peptide inside the membrane being targeted (Stone-Hulslander and Morrison, 1999). Biological activity of NDV is altered due to   destabilization of tetrameric structures of HN protein that occurs as a result of mutation in the heptad repeats (Ganar et al., 2014).

2.8. Nonstructural V and W proteins:

The P gene is transcribed into varying mRNAs that then translated into V and W proteins that have common amino-terminal domain with P protein (Rao et al., 2020). but different carboxyl termini. A molecular weight of 36 kDa and a length of 239 aa was determined to V protein of NDV (Lamb and Parks, 2007). This protein interacts with N protein and has a role in cell apoptosis and viral replication. Meanwhile, W protein modulates the inflammatory host immune response and considered as a potential virulence factor in vivo (Horikami et al., 1996; Gotoh et al., 2001; Jang et al., 2010 and Naz et al., 2022). Additionally, like all other Paramyxoviruses, V protein of ND virus contains C terminal domain that is rich in cysteine amino which binds two atoms of Zn2+ (Steward et al., 1995). Host IFN response is inhibited by V protein via inhibition of IFN signaling by degradation of STAT1 and interaction with MDA5 (Park et al., 2003).

  1. Viral replication and pathogenesis:

Infection of respiratory epithelial cells with NDV occurs via its surface glycoprotein that binds to sialic acid-containing compounds like gangliosides and N-glycoproteins receptors. Primarily, infection occurs via pH-independent fashion during viral envelope fusion with the host cell membrane. Additionally, infection can take place via receptor mediated endocytosis and occasionally through caveolae-dependent endocytosis (Cantin et al., 2007). Cell attachment is mediated by the HN protein, while the F protein is required for cell fusion (Smith et al., 2009). Nucleocapsid is released into the cytoplasm after fusion between virus envelope and host cell membrane. Viral negative sense RNA genome is then transcribed into positive sense mRNA which then translated into viral proteins (Dzogbema et al., 2021). Transcription takes place at the extreme leader sequence and the mRNA of individual genes is synthesized from gene-start to gene-end sequences. Distance from the 3’ end of the viral genome affects the gradient reduction of mRNA population that occurs as a result of ununiformity of transcription reinitiation to a downstream gene at the gene-start site (Ganar et al,. 2014). M protein and lipid raft over the cell membrane affects assembly and budding of mature NDV. The amino acid sequence of the cleavage site of F protein is considered as the primary determinant of infection (Panda et al., 2004; Peeters et al., 1999 and Samal et al., 2011). In addition, the virus can also spread in the host organism by forming syncytia (giant multinucleated cells) by fusion between infected cells expressing the HN and F glycoproteins (Ahamed et al., 2004 and Maminiaina, 2011). It was indicated that neurons and glial cells (astrocytes, microglia, and oligodendrocytes) are susceptible to virulent NDV. Neurotropic phenotype is determined by many factors other than cellular tropism (Butt et al., 2019. Human is susceptible to NDV that can cause conjunctivitis (Swayne and King, 2003)

 

 

  1. Transmission, clinical signs and lesions:

Outside the host and in the environment, the virus is relatively stable, so fomite transmission is possible. In the summer, infectious virus was found to survive 7 days, while in the spring virus can survive 14 days, and in the winter can survive 30 days in poultry houses (Kinde et al., 2004). Fomites are considered as vehicles for virus transmission or during an outbreak due to the high virus stability at multiple types of materials and at various temperatures (Olesiuk, 1951). Shedding of NDV occurs in feces and respiratory secretions from infected birds and primary transmission occurs via inhalation or ingestion of virus (Alexander, 1988 and Leighton and Heckert, 2007). Additionally, virus transmission occurs also vertically via egg to the hatching chick (Roy and Venugopalan, 2005). Furthermore, both chicken skin and bone marrow (if kept at refrigerated temperatures) harbor virus for many months has been (Brown and Bevins, 2017).

The incubation period of NDV infection is 2–15 days, with an average of 5-6 days (Hanson and Spalatin, 1978). Shedding of  infectious virus takes place for up to 1–2 weeks after infection in gallinaceous birds (chickens, grouse, turkeys, pheasants, and partridges), meanwhile, in psittacine birds (parrots, macaws, and parakeets) can shed infectious virus for several months to 1 year mainly via feces and respiratory secretions (Erickson et al., 1977 and Alexander, 2000). Very high mortality rate of up to 100% was reported for chicks born with virulent NDV infections, especially as maternal antibody levels weaned off (Alexander et al., 2012 and Brown and Bevins, 2017).

According to the clinical signs seen in NDV infected chickens asymptomatic, lentogenic or respiratory, mesogenic, neurotropic velogenic and viscerotropic velogenic, pathotypes were identified, from which velogenic pathotype is the most virulent (Alexander and Senne, 2008; OIE 2018; Amoia et al., 2021; Dzogbema et al., 2021). Viscerotropic velogenic strains are characterized by induction of primarily intestinal infection with hemorrhagic lesions, while a predominantly respiratory and neurological infection are characteristics of neurotropic velogenic (Miller et al., 2010). Additionally, velogenic infections especially in birds with partial immunity that develop a chronic infection are characterized by neurological signs which includes ataxia, torticollis, tremors, and paresis or paralysis of the legs or wings that develop several days post-infection (Brown and Bevins, 2017). Similar neurotropic signs are developed by both wild and domestic species. Respiratory and neurological signs are induced by mesogenic viruses but the infection is self-limiting, and in older birds mortality is rare unless there are secondary bacterial infections (Brown and Bevins, 2017). Velogenic and mesogenic strains are associated with lesions that often detected in the central alimentary tract, nervous system (CNS), renal system, or respiratory tract (Leighton and Heckert, 2007). In addition, layers show decreased egg production. Meanwhile, lentogenic strains cause only a mild respiratory infection. (Dzogbema et al. 2021).

  1. Diagnosis:

5.1. Viral isolation:

Viral isolation is the “gold standard” for the detection of viruses and is important for the prediction of epidemics and control of outbreaks, as well as for antiviral drug and vaccines development (Hsiung, 1984 and Mao et al., 2022). The respiratory secretions, spleen, brain, cecal tonsils and lung tissues are used to prepare sterile inoculation materials. Physiological saline or phosphate buffered solution (PBS) with antibiotic are added to make emulsion that is centrifuged to obtain the inoculation material. The isolation of NDV can be achieved by inoculation of samples into SPF (specific pathogen free) chicken embryo, chicken embryo kidney cells (CEKs), chicken embryo fibroblasts (CEFs), Hela cell lines, Vero cell lines, and Median–Darby bovine kidney (MDBK) cells, among which CEFs are used more frequently. The sterile materials are inoculated into allantoic cavity of 9-11 day-old SPF chicken embryos and incubated for 5 days for virus culture. The allantoic fluids are collected aseptically from embryos that died 24 h or more post-inoculation. CEFs, Vero or Hela cells are inoculated with sterile samples and incubated at 36 C. Cytopathic effects (CPE) in the form of rounding and cell fusion are observed within 24 to 48 h of inoculation. Additionally, NDV has the ability to propagate in Hepatocellular carcinoma (HCC) inducing CPE that includes rounding, detachment from the culture surface, and death (Chen et al., 2022). However, virus isolation is time-consuming and laborious, so it is suitable for testing large numbers of samples (Mao et al., 2022).

Viral virulence assay:

Mean death time (MDT) is a common diagnostic test that includes injecting samples into fertilized chicken eggs and calculating the hours required to kill the chicken embryo (Leighton and Heckert, 2007). Velogenic strains lead to death of embryos in under 60 hours; however, when embryos are exposed to lentogenic strains, they may survive for over 90 hours, while mesogenic strains cause death 60-90 hours (Dzogbema et al. 2021).

The intracerebral pathogenicity index (ICPI) involves the weighted scoring of clinical signs following an intracerebral in day old chicks. While the intravenous pathogenicity index (IVPI) calculates scores for clinical signs in 6-week-old chicks after intravenous injections (Nakamura et al., 2014). A score (0: normal; 1: sick; 2: dead) is given to each chick daily for eight days in case of intracerebral infection. The virulence of the virus strain is determined by the average of these scores. Lentogenic strains have a value below 0.7; meanwhile velogenic strains have an ICPI value above 1.5. The presence of a mesogenic strain is indicated by an ICPI value between 0.7 and 1.5. Similarly, Intravenous pathogenicity index (IVPI) can be calculated as the ICPI. A velogenic strain is indicated by an IVPI greater than 2.5 (Dzogbema et al. 2021). Further pathotyping is done through assessing the amino acid sequence located at the fusion site (Brown and Bevins (2017).

Plaque assay:

The virulence of the viral strain can determined in vitro as the Newcastle disease virus induces plaque formation on embryonic fibroblast cultures, with their size and shape depending on the virulence of the virus as mesogenic and velogenic strains are cytopathic to several cell line, meanwhile avirulant strain are poorly cytopathic. (Dzogbema et al., 2021). The mesogenic or avirulent strains induce less number of syncytia than the virulent strains. Supplementation of agar with 2.5 µg/ml trypsin, magnasium sulfate (0.03 M) and 0.02% DEAE dextran is the optimal condition for plaque assay of the avirulant LaSota strain (Mehrabanpour et al., 2007).

5.2. Hemagglutination (HA) and hemagglutination-inhibition (HI) tests:

Both hemagglutinin and neuraminidase activities are exhibited by NDV envelope. Different animals’ red blood cells (mainly chicken red blood cells) can be agglutinated in vitro by hemagglutinin. Dissociation of agglutinated red blood cells and virus release are done by neuraminidase. HA-HI tests can be used to identify the isolated NDV, and the biological characteristics of NDV determines hemagglutination titer and maternal antibody titer (Yu et al., 2012). HA test alone cannot make a definite diagnosis because of hemagglutination properties of other pathogens such as AIV. Therefore, it is necessary to use HI with known antiserum to identify the newly isolated virus definitively identification (Mao et al., 2022(.

5.3. Enzyme linked immunosorbent assay (ELISA):

            The ELISA method, known for its high specificity and sensitivity, is able to directly detect complex biological samples, making it a valuable tool for identifying specific antibodies in serum, and is commonly utilized for NDV detection) Brito et al., 2018; Juang et al., 2018; Tan et al., 2018; Orcajo et al., 2019 and Shang et al., 2019). Traditional ELISA that uses poly and monoclonal antibodies as reagents has difficulty in permanent storage, the need to use secondary antibodies and limited quantities, (Smirnov et al., 2018). Recombinant technology are used for fusion of nanobodies with multiple tags in their tertiary structure and expressed with different expression systems offering an effective diagnostic method. The nanobody-fused reporter (RANbody) and ferritin-fused nanobody (fenobodyhave been created based on the nanobody to develop diagnostic immunoassays (Mao et al., 2022). A sandwich ELISA was established for detection of NDV in clinical samples, using fenobody as capture antibody and RANbody as detection antibody (Ji et al., 2020). Nanobody-horseradish peroxidase (HRP) fusion protein was used as a probe in competitive ELISA (cELISA) that was used for detection of NDV antibodies in chicken serum (Sheng et al., 2019). antibody against the C-terminal region of the NDV structural protein P and nonstructural protein V were detected using P-ELISA and V-ELISA (Ahmed et al., 2012). Indirect ELISA was developed for the detection of NDV specific Japanese quail IgG (Oliveira et al., 2007).

 

5.4. Immunofluorescence assay:

Due to the false positive results and false negatives results of ELISA, the IFA is used as a confirmatory test for the detection of NDV. At IFA assay, a fluorescent probe (a fluorescein-labeled secondary antibody) is used and then the fluorescence is visualized with a fluorescent microscope to analyze the corresponding antigen (Mao et al. 2022).

 

 

5.5. Immunohistochemistry:

Immunohistochemistry staining is used to localize the antigen within the affected tissue via reaction between antibody and a specific antigen, which increases the accuracy of this assay as a diagnostic method (Etriwati et al., 2017).

5.6. Neutralization test:

The neutralization test (NT) can be used to identify unknown viral antibodies in the serum or to detect viruses using anti-NDV serum of known specificity (Mao et al., 2022). A novel neutralization test was used to assess neutralizing antibodies against NDV via the NDV-pseudotyped HIV-Luc viruses (Wang et al., 2014).

5.7. Molecular assays:

Molecular assays have been used as fast identifying and differentiating method to NDV (Mao et al., 2022).

5.7.1. Reverse transcription polymerase chain reaction (RT-PCR):

It is highly sensitive and considered the gold standard for the molecular detection of the virus (Mao et al., 2022). The main functional regions of the gene of NDV fusion protein was amplified using degenerate primers for the RT-PCR (Li et al., 2009). Hemosorption-based sensitive RT-PCR technology was used for detection of NDV giving 100 times higher sensitivity than the traditional RT-PCR detection methods (Desingu et al., 2016).

 

5.7.2. Real-time RT-PCR and DNA sequencing:

It is rapid and highly sensitive test with possibility of quantitative analysis and low false positive results. Real-time fluorescence-based reverse transcription which uses reverse transcription recombinase-aided amplification (RT-RAA) and exo probes for recombinase-aided amplification was used to detect NDV (Wang et al., 2020). Duplex real-time qPCR is feasible and effective for the simultaneous detection of NDV and AIV (Zhang et al. 2020). qRT-PCR method was used for fast, on-site detection of NDV on the farm (Liu et al., 2016). Three primer and probe sets for the M and F genes fragments of NDV were designated, and a qRT-PCR was developed to detect NDV (Wise et al., 2004). Several protocols were used for pathotyping and genotyping of all APMV-1 members in clinical samples or allantoic fluids from embryonated chicken eggs (Terregino and Capua, 2013).

Phylogenetic analysis of full sequences of F gene revealed dividing of class I NDV into 3 sub-genotypes within a single genotype, while class II NDV was divided into 21 genotypes (I–XXI) that subdivided into several subgenotypes (Dimitrov et al., 2019). Next-generation sequencing (NGS) was used to analyze the P-gene editing of NDV and PVW ratios that are stable along time among different NDVs (Chen et al., 2020). Real-time PCR SYBR Green I melting-curve analysis of the fusion (F) protein gene was developed by Pham et al., and the detection limit was 9 × 102 plasmid copies and was 100 times more sensitive than conventional PCR (Pham et al., 2005).

  1. Vaccination:

Application of biosecurity strategies and vaccination regimens are important for the prevention and control of NDV (Alexander 2000). Strict biosecurity measures can decrease the risk of animals being exposed infection. Adequate vaccine dose must be given to at least 85%  of birds, and a haemagglutination-inhibition (HI) antibody titer ≥3 log 2 must be elicited in these birds to achieve eligible herd immunity (Hu et al., 2022).

6.1. Live vaccines:

Live ND vaccines present low or no virulence, can induce mucosal, cellular and humoral immunity and can be given via drinking water or spraying. Nevertheless, live vaccines may cause undesirable reactions like mild respiratory signs, increased susceptibility to other pathogens and even mortalities (van Eck and Goren, 1991).

Mesogenic and lentogenic live vaccines (including B1, F, LaSota, V4, and I2) are commonly used (Shafaati et al., 2022). Protective antibody responses can be induced via lentogenic vaccines, although of difference in tissue replication pattern and tropism in chickens. La Sota and B1 belong to genotype II, show high similarities at the antigenic and genetic levels and are the most widely used among lentogenic strains and (Hu et al., 2022). The La Sota strain replicates to high levels in chickens and shows high tropism to the respiratory system (Perozo et al., 2008). Generally, high antibody titers are induced by La Sota, thus this vaccine is proper for use in countries endemic with virulent NDV. The B1 vaccine has a very low virulence, high safety to chicks and, and it usually used under low-level infection or in chicks. V4 and I2 vaccines have high thermal stability so are beneficial vaccines in the absence of a cold chain in remote regions (Bensink et al., 1999). Mukteswar and Komarov strains are mesogenic live vaccines showing high immunogenicity, high virulence, and mortality in young birds and therefore they are suitable for use as a booster dose of vaccine (Gallili and Ben-Nathan, 1998; Czegledi et al., 2003 and Senne et al., 2004). The minimum requirement for full protection and reduction of viral shedding by live vaccines is a dose of 106 EID50 (Cornax et al., 2012). Although the presence of a single serotype of NDV, there are great antigenic and genetic variations between field viruses and conventional live vaccines (Hu et al., 2022).

 

6.2. Inactivated vaccines:

Inactivated vaccine is also extensively used for ND control. To ensure complete loss of infectivity, the allantoic fluids must be performed β-propiolactone or formalin multiple times. Emulsified vaccines are prepared via adding of mineral oils as an adjuvants to inactivated allantoic (Gallili and Ben-Nathan, 1998). Lentogenic NDV strains, including La Sota, B1 and Ulster have high virus yield, thus they are usuallyused as the master seed. Although these vaccines have high safety, and induce high, long-lasting humoral immunity, they have a relatively high production cost, difficult administration (via a parenteral route such as subcutaneous or intramuscular injection) and poor induction of cellular or mucosal immune responses (Hu et al., 2022).

6.3. Recombinant vaccines:

6.3.1. DNA vaccines:

It can be produced via using of an expression plasmid for cloning of a gene encoding an immunogen or group of neutralizing epitopes which then is administered to the animal host for transcription and translation. Both HN and F proteins are the virus’ key virulence factors and they play an essential role in immunogenicity against the virus. Therefore, they are appropriate candidates for developing of recombinant vaccines (Shafaati et al., 2022). Administration of DNA vaccines leads to the production of cytokines and massive immune response (Sawant et al., 2011). Nanoparticles can improve the effectiveness of DNA vaccinations (Firouzamandi et al., 2016).

 

6.3.2. Viral Vector Vaccines:

The fowl pox, vaccinia, and turkey herpes viruses are the three most frequently used vectors in poultry (Weli and Tryland, 2011). The carrier virus is usually has a large genome size and can genetically express foreign genes along or instead of its own genes (Ewer et al., 2016). The large double-stranded DNA genomes of vaccinia viruses enable them expressing foreign genes with a very high capacity. Additionally they are able to induce high immunogenic and robust inflammatory responses (Shafaati et al., 2022)

6.3.3. Virus like particles:

Virus like particles are replication-incompetent structures that capable of stimulating immunity. They are resulted from the assembly of virus structural proteins in an expression system (like Baculovirus), making them (McGinnes et al., 2010 and Park et al., 2014).

6.3.4. Reverse genetics vaccines:

Reverse genetics is the most recent technique for production of genotype-matched live attenuated ND vaccines and it refers to the retrieval of a recombinant virus from its cloned cDNA (Pfaller et al., 2015). Reverse genetics can be used to produce genotype-matched vaccine via modifying the cleavage site of the virulent NDV from polybasic to monobasic (Shafaati et al., 2022). It was found that the conserved glutamine residue in the cleavage site of F protein is important for NDV pathogenicity and replication and virus can be attenuated by mutation of Q114R (Samal et al., 2011). Additionally, attenuation of NDV could also be achieved by substituting valine to isoleucine at position 118 around the cleavage site of F protein (Ganar et al., 2014)

 

  1. Conclusion:

ND is a global major threat to the poultry industry. NDV strains circulate among avian species, having varying degree of virulence. Virus structure is the determinant of its virulence. Improving tools of diagnosis and better vaccine development is the corner stone in the disease control. Strong protective efficiency, homogeneity with the most frequent NDV strains and genetic stability, indicate that reverse genetic will become more widely used in a range of countries in the near future.

 

AbdElfatah KS, Elabasy MA, El-khyate F, Elmahallawy EK, Mosad SM, El-Gohary FA, Abdo W, Al-Brakati A, Seadawy MG, Tahoon AE, et al. 2021. Molecular Characterization of Velogenic Newcastle Disease Virus (Sub-Genotype VII.1.1) from Wild Birds, with Assessment of Its Pathogenicity in Susceptible Chickens. Animals, 11: 505.
Ahamed T, Hossain KM, Billah MM, Islam KMD, Ahasan MM, Islam ME. 2004. Adaptation of Newcastle Disease Virus (NDV) on Vero Cell Line. Int. J. Poult. Sci., 3(2): 153–156.
Ahmed A, Guo X, Hashimoto W, Ohya K, Fukushi H. 2012. Establishment of nonstructural V and structural P protein-based elisas for detection of Newcastle disease virus infection. J Animal Vet. Adv., 11:4017–21.
Aldous E, Fuller C, Mynn J, Alexander D. 2004. A molecular epidemiological investigation of isolates of the variant avian paramyxovirus type 1 virus (PPMV-1) responsible for the 1978 to present panzootic in pigeons. Avian Pathol. 33, 258–269.
Alexander DJ. 1988. Newcastle disease: Modes of spread. In: Alexander DJ (ed) Newcastle disease, development of veterinary virology. Kluwer Academic Publishers, Boston, pp 256–272.
 Alexander DJ. 2000. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech, 19:443–462
Alexander DJ, Aldous EW, Fuller CM. 2012. The Long View: A Selective Review of 40 Years of Newcastle Disease Research. Avian Pathol., 41(4):329-335.
Alexander DJ, Senne DA. Newcastle Disease and Other Avian Paramyxoviruses. In: Dufour-Zavala L, Swayne DE, Glisson JR, Jackwood MW, Pearson JE, Reed WM, Woolcock PR, Editors. A Laboratory Manual for the Isolation, Identification and Characterization of Avian Pathogens, 4th ed. American Association of Avian Pathologists, Athens, GA; 2008, p. 135–141.
Ali AAH, Abdallah FM, Farag GK, Sameh K. 2022. A Mini-Review on Newcastle Disease Virus in Egypt, With Particular References to Common Vaccines and Their Development. Zag Vet J, 50 (1): 19-36.
Amer SA, Ali MA, Kandeil AM, Kutkat MA. 2019. Advancement in Vaccination of Broiler Chickens with GenotypeMatched Vaccines to Currently Epidemic Newcastle Disease Virus Genotype VII in Egypt. J World Poult Res, 9(3): 117-123.
Amoia CFAN, Nnadi PA, Ezema C, CouacyHymann E. 2021. Epidemiology of Newcastle disease in Africa with emphasis on Côte d’Ivoire: A review. Vet. World. 14(7): 1727-1740.
Bellini WJ, Englund G, Richardson CD, Rozenblatt S, Lazzarini RA. 1986. Matrix Genes of Measles Virus and Canine Distemper Virus: Cloning, Nucleotide Sequences, and Deduced Amino Acid Sequences. J. Virol., 58(2): 408–416.
Bello MB, Yusof K, Ideris A, Hair-Bejo M, Peeters BPH, Omar AR (2018) Diagnostic and vaccination approaches for Newcastle disease virus in poultry: the current and emerging perspectives. Biomed Res Int, 2018:7278459
Bensink Z, Spradbrow P. 1999. Newcastle disease virus strain I2–a prospective thermostable vaccine for use in developing countries. Vet Microbiol., 68; 131-9.
Bossart KN, Fusco DL, Broder CC. 2013. Paramyxovirus Entry. Adv. Exp. Med. Biol., 790: 95–127.
Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder C. 2009. A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection. PLoS Pathog., 5(10): 1- 11.
Brito LF, Mallikarjunappa S, Sargolzaei M, Koeck A, Chesnais J, Schenkel FS, et al. 2018. The genetic architecture of milk ELISA scores as an indicator of Johne’s disease (paratuberculosis) in dairy cattle. J Dairy Sci., 101:10062–75.
Brown VR. and Bevins SN. 2017. A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread. Vet Res, 48:68.
Butt SL, Moura VMBD, Susta L, Miller PJ, Hutcheson JM, Cardenas-Garcia S, Brown CC, West FD, Afonso CL, Stanton JB. 2019. Tropism of Newcastle disease virus strains for chicken neurons, astrocytes, oligodendrocytes, and microglia. BMC Vet Res., 4;15(1):317.
Cantin, C, Holguera, J, Ferreira, L, Villar, E, Munoz-Barroso, I, 2007. Newcastle disease virus may enter cells by caveolae-mediated endocytosis. J. Gen. Virol. 88 (2), 559–569.
Chambers P, Millar NS, Platt SG, Emmerson PT. 1986. Nucleotide sequence of the gene encoding the matrix protein of Newcastle disease virus. Nucleic Acids Res., 14(22): 9051–9061.
Chen L, Niu Y, Sun J, Lin H, Liang G, Xiao M, Shi D, Wang J, Zhu H, Guan Y. 2022. Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling. J Clin Transl Hepatol. 28;10(2):284-296. 
Chen X, Jia Y, Ren S, Chen S, Wang X, Gao X, Wang C, Adam FE A, Wang X., Yang, Z. 2020. Identification of Newcastle disease virus P-gene editing using next-generation sequencing. The Journal of veterinary medical science, 82(8), 1231–1235. 
Connaris H, Takimoto T, Russell R, Crennell S, Moustafa I, Portner A, et al. 2002.  Probing the sialic acid binding site of the hemagglutininneuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J Virol., 76:1816–24.
Connolly SA, Leser GP, Jardetzky TS, Lamb RA. 2009. Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol., 83:10857–68
Cornax I, Miller PJ, Afonso CL. 2012. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype. Avian Dis 56:464–470
Czegledi A, Wehmann E, Lomniczi B. 2003. On the origins and relationships of Newcastle disease virus vaccine strains Hertfordshire and Mukteswar, and virulent strain Herts’33. Avian Pathol 32:271–276
Czeglédi, A., Ujvári, D., Somogyi, E., Wehmann, E., Werner, O., Lomniczi, B., 2006. Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res. 120, 36–48.
da Silva, A.P., Aston, E.J., Chiwanga, G.H., Birakos, A., Muhairwa, A.P., Kayang, B.B., Kelly, T., Zhou, H., Gallardo, R.A. 2020. Molecular Characterization of Newcastle Disease Viruses Isolated from Chickens in Tanzania and Ghana. Viruses. 12 (9): 916.
deLeeuw, O.S., Koch, G., Hartog, L., Ravenshorst, N., Peeters, B.P.H. 2005. Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin–neuraminidase protein. J. Gen. Virol. 86 (6): 1759–1769.
Deng R, Wang Z, Mirza AM, Iorio RM. 1995. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology. 209:457–69.
Desingu PA, Singh SD, Dhama K, Vinodhkumar OR, Malik YS, A. 2016.  sensitive haemadsorption technique based RT-PCR for concentration and detection of Newcastle disease virus from clinical samples and allantoic fluid. Virusdisease. 27:319–23.
Dimitrov, KM, Abolnik, C, Afonso, CL, Albina, E, Bahl, J, Berg, M, Briand, F.-X., Brown, IH, Choi, K- S, Chvala, I, et al. 2019. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect. Genet. Evol. 74: 103917.
Dortmans, JC, Rottier, PJ, Koch, G, Peeters, BP, 2010. The viral replication complex is associated with the virulence of Newcastle disease virus. J. Virol. 84 (19), 10113–10120.
Dzogbema K F , Talaki E, Batawui K B,Dao B B. Review on Newcastle disease in poultry. Int. J. Biol. Chem. Sci. 15(2): 773-789, 2021.
Erickson GA, Maré CJ, Gustafson GA, Miller LD, Carbrey EA. 1977. Interactions between viscerotropic velogenic Newcastle disease virus and pet birds of six species. II. Viral evolution through bird passage. Avian Dis 21:655–669
Errington, W, Emmerson, PT, 1997. Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein. J. Gen. Virol. 78 (Pt 9), 2335–2339.
Etriwati, Ratih D, Handharyani E, Setiyaningsih S. 2017. Pathology and immunohistochemistry study of Newcastle disease field case in chicken in Indonesia. Vet World.;10(9):1066-1071.
Ewer, KJ; Lambe, T; Rollier, CS; Spencer, AJ, Hill, AV, Dorrell, L. 2016. Viral vectors as vaccine platforms: from immunogenicity to impact. Curr. Opin. Immunol., 41,47–54.
Firouzamandi M, Moeini H, Hosseini SD, Bejo MH, Omar AR, Mehrbod P, et al. 2016. Preparation, characterization, and in ovo vaccination of dextranspermine nanoparticle DNA vaccine coexpressing the fusion and hemagglutinin genes against Newcastle disease. Int J Nanomedicine.; 11: 259.
Gallili GE, Ben-Nathan D. 1998. Newcastle disease vaccines. Biotechnol Adv 16:343–366
Ganar K, Das M, Sinha S, Kumar S.  2014. Newcastle disease virus: Current status and our understanding. Virus Research 184 71–81.
Gorman, JJ, Nestorowicz, A, Mitchell, SJ, Corino, GL, Selleck, PW, 1988. Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursors. J. Biol. Chem., 263 (25): 12522–12531.
Hanson RP, Spalatin P. 1978. Thermostability of the Hemagglutinin of Newcastle Disease Virus as a Strain Marker in Epizootiologic Studies. Avian. Dis., 22(4) 659-665.
Hernandez LD, Hoffman LR, Wolfsberg TG, White JM. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev Biol., 12(1): 621-661.
Horikami, S.M., Smallwood, S., Moyer, S.A., 1996. The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology 222 (2), 383–390.
Hsiung GD. 1984. Diagnostic virology: from animals to automation. Yale J Biol Med., 57:727–33.
Hu Z, He X, Deng J, Hu J and Liu X. 2022. Current situation and future direction of Newcastle disease vaccines Vet Res 53:99
Hu, X.L., Ray, R., Compans, R.W., 1992. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol. 66 (3), 1528–1534.
Iorio, R.M., Mahon, P.J., 2008. Paramyxoviruses: different receptors – different mechanisms of fusion. Trends Microbiol. 16 (4), 135–137.
Jahanshiri, F., Eshaghi, M., Yusoff, K., 2005. Identification of phosphoprotein:phosphoprotein and phosphoprotein:nucleocapsid protein interaction domains of the Newcastle disease virus. Arch. Virol. 150 (3), 611–618.
Ji P, Zhu J, Li X, Fan W, Liu Q, Wang K, et al. 2020. Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus. J Nanobiotechnol. 18:44.
Juang DS, Lin CH, Huo YR, Tang CY, Cheng CR, Wu HS, et al. 2018. Proton-ELISA: Electrochemical immunoassay on a dual-gated ISFET array. Biosens Bioelectron. 117:175–82.
Kattenbelt, J.A., Stevens, M.P., Gould, A.R., 2006. Sequence variation in the Newcastle disease virus genome. Virus Res. 116 (1–2), 168–184.
Kho CL, Tan WS, Tey BT, Yusoff K. 2003. Newcastle Disease Virus Nucleocapsid Protein: Self-Assembly and LengthDetermination Domains. J. Gen. Virol., 84: 2163-2168.
Kinde H, Utterback W, Takeshita K, McFarland M. 2004. Survival of exotic Newcastle disease virus in commercial poultry environment following removal of infected chickens. Avian Dis 48:669–674
Kopecky SA, Lyles DS. 2003. Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression. J. Virol., 77(8): 4658-4669.
Lamb RA, Parks GD. 2007. Paramyxoviridae: the viruses and their replication. In Fields BN, D. Knipe N, Howley PM, editors. Fields virology: Fifth Edition. Lippincott, Williams, and Wilkins, p. 1449-1496.
Leighton FA, Heckert RA. 2007. Newcastle disease and related avian paramyxoviruses. In: Thomas NJ, Hunter DB, Atkinson CT (eds) Infectious diseases of wild birds. Blackwell Publishing, Oxford, pp 3–16
Li X, Qiu Y, Yu A, Chai T, Zhang X, Liu J, et al. 2009. Degenerate primers based RT-PCR for rapid detection and differentiation of airborne chicken Newcastle disease virus in chicken houses. J Virol Methods, 158:1–5.
Liu L, Benyeda Z, Zohari S, Yacoub A, Isaksson M, Leijon M, et al. 2016. Assessment of preparation of samples under the field conditions and a portable real-time RT PCR assay for the rapid on-site detection of Newcastle disease virus. Transbound Emerg Dis., 63:E245–50.
Maminiaina OF. 2011. Caractérisation Des Virus de La Maladie de Newcastle (APMV-1), Circulant Sur Les Hautes Terres de Madagascar. PhD thesis Universite d’Antananarivo, Madagascar, p 215.
Mao Q, Ma S, Schrickel PL, Zhao P, Wang J, Zhang Y, Li S, Wang C. 2022. Review detection of Newcastle disease virus. Front. Vet. Sci. 9:936251.
McGinnes, L.W., Morrison, T.G., 1994. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus. Virology 200 (2), 470–483.
McGinnes, LW; Pantua, H; Laliberte, JP; Gravel, KA; Jain, S and Morrison, TG. 2010. Assembly and biological and immunological properties of Newcastle disease virus-like particles. J. Virol., 84:4513–4523.
Mehrabanpour MJ, Dadras   H, Pourbakhsh  SA, Hoseini SMH, Motamedifar  M, Mohammadi  A. 2007. Plaque formation of LaSota pathogenic strain of Newcastle disease virus adapted in chick embryo fibroblast cells. Arch Razi Instit, 62 (1): 7-13.
Melanson,V.R., Iorio, R.M., 2004. Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J. Virol. 78 (23), 13053–13061.
Miller PJ, Decanini EL, Afonso CL. 2010. Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infect Genet Evol 10:26–35.
Mirza, A.M., Iorio, R.M., 2013. A mutation in the stalk of the newcastle disease virus hemagglutinin-neuraminidase (HN) protein prevents triggering of the F protein despite allowing efficient HN–F complex formation. J. Virol. 87 (15), 8813–8815.
Nagai, Y., Klenk, H.D., Rott, R., 1976. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72 (2), 494–508.
Nagy A., Ali, A., Zain El-Abideen, M.A., Kilany, W., Elsayed, M. 2020. Characterization and genetic analysis of recent and emergent virulent Newcastle disease viruses in Egypt. Transbound. Emerg. Dis. 00:1–13.
Nakamura K,  Ito M,  Nakamura T,  Yamamoto Y, Yamada M, Mase M,  Imai K. 2014. Pathogenesis of Newcastle disease in vaccinated chickens: pathogenicity of isolated virus and vaccine effect on challenge of its virus. J Vet Med Sci.,  76(1): 31–36
Naz D, Rahmana S  , Aslama M A, Muhammad F. 2022. Newcastle disease virus in poultry with an interface as a human vector. Veterinary Vaccine 1: 100003.
OIE. 2018. Newcastle disease (infection with Newcastle disease virus). In OIE Manual of Standards for Diagnostic Tests and Vaccines; Chapter 2.3.14; OIE: Paris, France.
Olesiuk OM. 1951. Infuence of environmental factors on viability of Newcastle disease virus. Am J Vet Res 43:152–155
Oliveira DD, Folgueras-Flatschart AV, Flatschart RB, Resende JS, Abreu JT, Martins NRS. 2007. Indirect ELISA for the detection of IgG specific to Newcastle disease virus in quail serum. Arq Bras Med Vet Zoo., 59:1344–7.
Orcajo J, Lavilla M. Martinez-de-Maranon I. 2019. Specific and sensitive ELISA for measurement of IgE-binding variations of milk allergen betalactoglobulin in processed foods. Anal Chim Acta, 1052:163–9.
Panda, A., Huang, Z., Elankumaran, S., Rockemann, D.D., Samal, S.K., 2004. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb. Pathog. 36 (1), 1–10.
Park JK, Lee DH, Yuk SS, Tseren-Ochir EO, Kwon JH, Noh JY, et al. 2014. Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals. Clin. Vaccine Immunol., 21:360–365.
Park, M.S., Garcia-Sastre, A., Cros, J.F., Basler, C.F., Palese, P., 2003. Newcastle disease virus V protein is a determinant of host range restriction. J. Virol. 77 (17), 9522–9532.
Peeples, M.E., Bratt, M.A., 1984. Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity. J. Virol. 51 (1), 81–90.
Peeters BPH, Gruijthuijsen YK, De Leeuw OS, Gielkens ALJ. 2000. Genome replication of Newcastle disease virus: Involvement of the Rule-of-Six. Arch. Virol., 145(9) 1829-1845.
Peeters, B.P., de Leeuw, O.S., Koch, G., Gielkens, A.L., 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73 (6), 5001–5009.
Perozo F, Villegas P, Dolz R, Afonso CL, Purvis LB. 2008. The VG/GA strain of Newcastle disease virus: mucosal immunity, protection against lethal challenge and molecular analysis. Avian Pathol 37:237–245
Pfaller CK, Cattaneo R, Schnell MJ. 2015. Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics. Virology, 479: 331-44.
Pham H, Konnai, S, Usui T,  Chang KS,  Murata S,  Mase M, Ohashi K Onuma M. 2005. Rapid detection and differentiation of Newcastle disease virus by real-time PCR with melting-curve analysis. Arch Virol., 150, 2429–2438.
Rao, PL, Gandham, RK, Subbiah, M, 2020. Molecular evolution and genetic variations of V and W proteins derived by RNA editing in Avian Paramyxoviruses. Sci. Rep. 10,1–16.
Rauw. F, Gardin, Y, van den Berg, T, Lambrecht, B. 2009. La vaccination contre la maladie de Newcastle chez le poulet (Gallus gallus). Biotechnol. Agron. Soc. Environ. 13(4): 587-596.
Ravishankar C, Ravindran R, John AA, Divakar N, Chandy G, Joshi V, Chaudhary D, Bansal N, Singh R, Sahoo N, Mor SK, Mahajan NK, Maan S, Jindal N, Schilling MA, Herzog CM, Basu S, Radzio-Basu J, Kapur V, Goyal SM. 2022. Detection of Newcastle disease virus and assessment of associated relative risk in backyard and commercial poultry in Kerala, India. Vet Med Sci.; 8:1146–1156.
Römer-Oberdörfer A, Werner O, Veits J, Mebatsion T, Mettenleiter TC. 2003. Contribution of the Length of the HN Protein and the Sequence of the F Protein Cleavage Site to Newcastle Disease Virus Pathogenicity. J. Gen. Virol., 84(11): 3121-3129.
Rout, S.N., Samal, S.K., 2008. The large polymerase protein is associated with the virulence of Newcastle disease virus. J. Virol. 82 (16), 7828–7836.
Roy P, Venugopalan AT. 2005. Unexpected Newcastle disease virus in day old commercial chicks and breeder hens. Comp Immunol Microbiol Infect Dis 28:277–285.
Samal, S., Kumar, S., Khattar, S.K., Samal, S.K., 2011. A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity. J. Gen. Virol. 92 (10), 2333–2338
Sawant P, Verma P, Subudhi P, Chaturvedi U, Singh M, Kumar R, et al. 2011. Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes. Vet Immunol Immunopathol.; 144: 36-44.
Seal BS, Wise MG, Pedersen JC, Senne DA, Alvarez R, Scott MS, King DJ, Yu Q, Kapczynski DR. 2005. Genomic Sequences of Low-Virulence Avian Paramyxovirus-1 (Newcastle Disease Virus) Isolates Obtained from Live-Bird Markets in North America Not Related to Commonly Utilized Commercial Vaccine Strains. Veterinary Microbiology., 106(1- 2): 7-16.
Seal, B.S., King, D.J. and Meinersmann, R.J., 2000. Molecular evolution of the Newcastle disease virus matrix protein gene and phylogenetic relationships among the paramyxoviridae. Virus Res. 66 (1), 1–11.
Senne D, King D, Kapczynski D. by Vaccination. Dev Biol Basel. 2004; 119 :165-70.
Sergel, T, McGinnes, LW, Peeples, ME, Morrison, TG, 1993. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193 (2), 717–726.
Seth S, Skountzou I, Gernert KM, Compans RW. 2007. Fusogenic Variants of a Noncytopathic Paramyxovirus. J. Virol., 81(8): 4286-4297.
Shafaati M, Ebadi M, Ghorbani M. 2022. A Short Review of Progress in Development of Newcastle Disease Vaccines. J Vet Med Res 9(2): 1231.
 Shang L, Xue G, Gong L, Zhang Y, Peng S, Yuan C, et al. 2019. Novel ELISA for the detection of active form of plasminogen activator inhibitor-1 based on a highly specific trapping agent. Anal Chim Acta., 1053:98–104.
Sheng Y, Wang K, Lu Q, Ji P, Liu B, Zhu J, et al. 2019. Nanobody-horseradish peroxidase fusion protein as an ultrasensitive probe to detect antibodies against Newcastle disease virus in the immunoassay. J Nanobiotechnology. 17:35.
Smirnov IV, Gryazeva IV, Vasileva MY, Krutetskaia IY, Shashkova OA, Samoylovich MP, et al. 2018. New highly sensitive sandwich ELISA system for soluble endoglin quantification in different biological fluids. Scand J Clin Lab Invest., 78:515–23.
Smith EC, Popa A, Chang A, Masante C, Dutch RE. 2009. Viral Entry Mechanisms: The Increasing Diversity of Paramyxovirus Entry. FEBS J., 276(24): 7217-7227.
Steward, M., Samson, A.C.R., Errington, W., Emmerson, P.T., 1995. The Newcastle disease virus V protein binds zinc. Arch. Microbiol. 140, 1321–1328.
Stone-Hulslander, J., Morrison, T.G., 1999. Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J. Virol. 73 (5), 3630–3637.
Swayne, DE, King, DJ. 2003. Avian influenza and Newcastle disease. J. Am. Vet. Med. Assoc. 222(11): 1534-1540.
Tan X, David A, Day J, Tang H, Dixon ER, Zhu H, et al. 2018Rapid mouse follicle stimulating hormone quantification and estrus cycle analysis using an automated microfluidic chemiluminescent ELISA system. ACS Sens. 3:2327–34.
Tamura K, Stecher G, Kumar S. 2021. MEGA11: Molecular evolutionary genetics analysis version 11. Mol. Biol. Evol., (38): 3022-3027.
Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H. 1992. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J. Virol., 66(12) 7211-7216.
Terregino C, Capua I. 2013. Méthode conventionnelle de diagnostic de l’infection par le virus de la maladie de Newcastle. In influenza aviaire et maladie de Newcastle., Springer Paris. 129-131.
Toyoda, T., Sakaguchi, T., Imai, K., Inocencio, N.M., Gotoh, B., Hamaguchi, M., Nagai, Y., 1987. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158 (1), 242–247.
van Eck JH, Goren E. 1991. An Ulster 2C strain-derived Newcastle disease vaccine: vaccinal reaction in comparison with other lentogenic Newcastle disease vaccines. Avian Pathol 20:497–507
Wang B, Wang B, Liu P, Li T, Si W, Xiu J, et al. 2014. Package of NDV-pseudotyped HIV-Luc virus and its application in the neutralization assay for NDV infection. PLoS ONE., 9:e99905
Wang W, Wang C, Bai Y, Zhang P, Yao S, Liu J, et al. 2020. Establishment of reverse transcription recombinase-aided amplification-lateral-flow dipstick and real time fluorescence-based reverse transcription recombinase-aided amplification methods for detection of the Newcastle disease virus in chickens. Poultry Sci. 99:3393–401.
Weli SC, Tryland M. 2011. Avipoxviruses: infection biology and their use as vaccine vectors. Virol J., 8: 1-15.
Wise MG, Suarez DL, Seal BS, Pedersen JC, Senne DA, King DJ, et al. 2004. Development of a real-time reverse-transcription PCR for detection of Newcastle disease virus RNA in clinical samples. J Clin Microbiol., 42:329–38
Yamakawa I, Tsurudome M, Kawano M, Nishio M, Komada H, Ito M, Uji Y, Ito Y. 2007. Failure of Multinucleated Giant Cell Formation in K562 Cells Infected with Newcastle Disease Virus and Human Parainfluenza Type 2 Virus. Microbiol. Immunol., 51(6): 601-608.
Yu Y, Qiu X, Xu D, Zhan Y, Meng C, Wei N, et al. 2012Rescue of virulent class I Newcastle disease virus variant 9a5b-D5C1. Virol J., 9:120.
Yusoff K and Tan W S. 2001. Newcastle Disease Virus: Macromolecules and Opportunities. Avian Pathol., 30(5): 439- 455.
Zhang X, Yao M, Tang Z, Xu D, Luo Y, Gao Y, et al. 2020. Development and application of a triplex real-time PCR assay for simultaneous detection of avian influenza virus, Newcastle disease virus, and duck Tembusu virus. Bmc Vet Res., 16:203.